vtioВестник трансплантологии и искусственных органовRussian Journal of Transplantology and Artificial Organs1995-1191Academician V.I.Shumakov National Medical Research Center of Transplantology and Artificial Organs", Ministry of Health of the Russian Federation10.15825/1995-1191-2020-4-173-182vtio-1281Research ArticleКлинические наблюденияClinical CasesХронический миокардит тяжелого течения, верифицированный как гигантоклеточный: неизбежный выбор в пользу трансплантации сердцаVerified chronic severe giant cell myocarditis: an inevitable choice for heart transplantationБлаговаО. В.BlagovaO. V.
119992, Москва, ул. Б. Пироговская, д. 6, стр. 1
Тел. (499) 248-62-33
6/1, B. Pirogovskaya str., Moscow, 119992, Russian Federation
Phone: (499) 248-62-33
blagovao@mail.ruЛутохинаЮ. А.LutokhinaYu. A.АйнетдиноваД. Х.AinetdinovaD. H.СедовВ. П.SedovV. P.ВоловченкоА. Н.VolovchenkoA. N.ПарфеновД. А.ParfenovD. A.МожейкоН. П.MozheikoN. P.ФГАОУ ВО «Первый Московский государственный медицинский университет имени И.М. Сеченова» Минздрава России (Сеченовский университет)РоссияSechenov UniversityRussian FederationФГБУ «Национальный медицинский исследовательский центр трансплантологии и искусственных органов имени академика В.И. Шумакова» Минздрава РоссииРоссияShumakov National Medical Research Center of Transplantology and Artificial OrgansRussian Federation202027012021224173182Copyright © Благова О.В., Лутохина Ю.А., Айнетдинова Д.Х., Седов В.П., Воловченко А.Н., Парфенов Д.А., Можейко Н.П., 20212021Благова О.В., Лутохина Ю.А., Айнетдинова Д.Х., Седов В.П., Воловченко А.Н., Парфенов Д.А., Можейко Н.П.Blagova O.V., Lutokhina Y.A., Ainetdinova D.H., Sedov V.P., Volovchenko A.N., Parfenov D.A., Mozheiko N.P.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://journal.transpl.ru/vtio/article/view/1281гигантоклеточный миокардитсердечная недостаточностьаневризма левого желудочкаантикардиальные антителатрансплантация сердцаgiant cell myocarditisheart failureleft ventricular aneurysmanticardiac antibodiesheart transplantationReferencesГотье СВ, Попцов ВН, Колоскова НН, Захаревич ВМ, Шевченко АО, Муминов ИИ и др. Лист ожидания трансплантации сердца ФГБУ «НМИЦ ТИО имени академика В.И. Шумакова». Тенденции за период с 2010-го по 2017 год. Вестник трансплантологии и искусственных органов. 2018; 20 (4): 8–13. doi.org/10.15825/1995-1191-2018-4-8-13.Gautier SV, Poptsov VN, Koloskova NN, Zakharevich VM, Shevchenko AО, Muminov II et al. Heart transplantation waiting list of V.I. Shumakov National Medical Research Center of Transplantology and Artificial Organs. Trends from 2010 to 2017. Russian Journal of Transplantology and Artificial Organs. 2018; 20 (4): 8–13. [In Russ.,English abstract]. doi.org/10.15825/1995-1191-2018-4-8-13.Caforio AL, Pankuweit S, Arbustini E et al. European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J. 2013; 34 (33): 2636–2648, 2648a–2648d. doi: 10.1093/eurheartj/eht210.Caforio AL, Pankuweit S, Arbustini E et al. European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J. 2013; 34 (33): 2636–2648, 2648a–2648d. doi: 10.1093/eurheartj/eht210.Bozkurt B, Colvin M, Cook J, Cooper LT, Deswal A, Fonarow GC et al. American Heart Association Committee on Heart Failure and Transplantation of the Council on Clinical Cardiology; Council on Cardiovascular Disease in the Young; Council on Cardiovascular and Stroke Nursing; Council on Epidemiology and Prevention; and Council on Quality of Care and Outcomes Research. Current Diagnostic and Treatment Strategies for Specific Dilated Cardiomyopathies: A Scientific Statement From the American Heart Association. Circulation. 2016; 134 (23): e579–e646. PMID: 27832612, doi: 10.1161/CIR.0000000000000455.Bozkurt B, Colvin M, Cook J, Cooper LT, Deswal A, Fonarow GC et al. American Heart Association Committee on Heart Failure and Transplantation of the Council on Clinical Cardiology; Council on Cardiovascular Disease in the Young; Council on Cardiovascular and Stroke Nursing; Council on Epidemiology and Prevention; and Council on Quality of Care and Outcomes Research. Current Diagnostic and Treatment Strategies for Specific Dilated Cardiomyopathies: A Scientific Statement From the American Heart Association. Circulation. 2016; 134 (23): e579–e646. PMID: 27832612, doi: 10.1161/CIR.0000000000000455.Благова ОВ, Осипова ЮВ, Недоступ АВ, Коган ЕА, Сулимов ВА. Клинические, лабораторные и инструментальные критерии миокардита, установленные в сопоставлении с биопсийным исследованием миокарда (алгоритм неинвазивной диагностики). Терапевтический архив. 2017; 89 (9): 30–40. doi: 10.17116/terarkh201789930-40.Blagova OV, Osipova YV, Nedostup AV, Kogan EA, Sulimov VA. Clinical, laboratory and instrumental criteria for myocarditis, established in comparison with myocardial biopsy: A non-invasive diagnostic algorithm. Ter Arkh. 2017; 89 (9): 30–40. [In Russ., English abstract]. doi: 10.17116/terarkh201789930-40.Ammirati E, Camici PG. Still poor prognosis for patients with giant cell myocarditis in the era of temporary mechanical circulatory supports. Int J Cardiol. 2018; 253: 122–123. doi: 10.1016/j.ijcard.2017.10.124.Ammirati E, Camici PG. Still poor prognosis for patients with giant cell myocarditis in the era of temporary mechanical circulatory supports. Int J Cardiol. 2018; 253: 122–123. doi: 10.1016/j.ijcard.2017.10.124.Maleszewski JJ, Orellana VM, Hodge DO, Kuhl U, Schultheiss HP, Cooper LT. Long-term risk of recurrence, morbidity and mortality in giant cell myocarditis. Am J Cardiol. 2015 Jun 15; 115 (12): 1733–1738. doi: 10.1016/j.amjcard.2015.03.023.Maleszewski JJ, Orellana VM, Hodge DO, Kuhl U, Schultheiss HP, Cooper LT. Long-term risk of recurrence, morbidity and mortality in giant cell myocarditis. Am J Cardiol. 2015 Jun 15; 115 (12): 1733–1738. doi: 10.1016/j.amjcard.2015.03.023.Elamm CA, Al-Kindi SG, Bianco CM, Dhakal BP, Oliveira GH. Heart Transplantation in Giant Cell Myocarditis: Analysis of the United Network for Organ Sharing Registry. J Card Fail. 2017; 23 (7): 566–569. doi: 10.1016/j.cardfail.2017.04.015.Elamm CA, Al-Kindi SG, Bianco CM, Dhakal BP, Oliveira GH. Heart Transplantation in Giant Cell Myocarditis: Analysis of the United Network for Organ Sharing Registry. J Card Fail. 2017; 23 (7): 566–569. doi: 10.1016/j.cardfail.2017.04.015.Благова ОВ, Недоступ АВ. Современные маски миокардита (от клинических синдромов к диагнозу). Российский кардиологический журнал. 2014; 19 (5): 13–22. doi.org/10.15829/1560-4071-2014-5-13-22.Blagova OV, Nedostup AV. Сontemporary masks of the myocarditis (from clinical signs to diagnosis). Russian Journal of Cardiology. 2014; (5): 13–22. [In Russ., English abstract]. doi.org/10.15829/1560-4071-2014-5-13-22.Cooper LT Jr, Berry GJ, Shabetai R. Idiopathic giant-cell myocarditis – natural history and treatment. Multicenter Giant Cell Myocarditis Study Group Investigators. N Engl J Med. 1997; 336 (26): 1860–1866. doi: 10.1056/NEJM199706263362603.Cooper LT Jr, Berry GJ, Shabetai R. Idiopathic giant-cell myocarditis – natural history and treatment. Multicenter Giant Cell Myocarditis Study Group Investigators. N Engl J Med. 1997; 336 (26): 1860–1866. doi: 10.1056/NEJM199706263362603.Ekström K, Lehtonen J, Kandolin R, Räisänen-Sokolowski A, Salmenkivi K, Kupari M. Long-term outcome and its predictors in giant cell myocarditis. Eur J Heart Fail. 2016, 18: 1452–1458. doi: 10.1002/ejhf.606.Ekström K, Lehtonen J, Kandolin R, Räisänen-Sokolowski A, Salmenkivi K, Kupari M. Long-term outcome and its predictors in giant cell myocarditis. Eur J Heart Fail. 2016, 18: 1452–1458. doi: 10.1002/ejhf.606.Ammirati E, Roghi A, Oliva F, Turazza FM, Frigerio M, Pedrotti P. Ventricular aneurysm as a complication of giant cell myocarditis. [Article in Italian]. G Ital Cardiol (Rome). 2015; 16 (6): 389–390. doi: 10.1714/1934.21040.Ammirati E, Roghi A, Oliva F, Turazza FM, Frigerio M, Pedrotti P. Ventricular aneurysm as a complication of giant cell myocarditis. [Article in Italian]. G Ital Cardiol (Rome). 2015; 16 (6): 389–390. doi: 10.1714/1934.21040.Благова ОВ, Недоступ АВ, Коган ЕА, Седов ВП, Донников АЕ, Кадочникова ВВ и др. ДКМП как клинический синдром: результаты нозологической диагностики с применением биопсии миокарда и дифференцированного лечения у вирус-позитивныхBlagova OV, Nedostup AV, Kogan EA, Sedov VP, Donnikov AE, Kadochnikova VV et al. DCMP as a clinical syndrome: results of nosological diagnostics with myocardial biopsy and differentiated treatment in virus-positive and virus-negative patients. Russian Journal of Cardiology. 2016; 21 (1): 7–19. [In Russ., English abstract]. doi.org/10.15829/1560-4071-2016-1-7-19.и вирус-негативных больных. Российский кардиологический журнал. 2016; 21 (1): 7–19. doi.org/10.15829/1560-4071-2016-1-7-19.Gautier SV, Shevchenko AO, Kormer AYa, Poptsov VN, Saitgareev RSh, Shumakov DV, Zakharevich VM. Three decades of heart transplantation in the Shumakov center: long-term outcomes. Vestnik transplantologii i iskusstvennyh organov. 2015; XVII (2): 70–73. doi.org/10.15825/1995-1191-2018-4-8-13.Готье СВ, Шевченко АО, Кормер АЯ, Попцов ВН, Саитгареев РШ, Шумаков ДВ, Захаревич ВМ. Три десятилетия трансплантации сердца в ФНЦТИО имени академика В.И. Шумакова: отдаленные результаты. Вестник трансплантологии и искусственных органов. 2015, 17 (2): 70–73. doi.org/10.15825/1995-1191-2018-4-8-13.Gkouziouta A, Miliopoulos D, Karavolias G, Lazaros G, Kaklamanis L, Kelepeshis G et al. Acute cytomegalovirus infection triggering fatal giant cell myocarditis. Int J Cardiol. 2016; 214: 204–206. doi: 10.1016/j.ijcard.2016.03.202.Gkouziouta A, Miliopoulos D, Karavolias G, Lazaros G, Kaklamanis L, Kelepeshis G et al. Acute cytomegalovirus infection triggering fatal giant cell myocarditis. Int J Cardiol. 2016; 214: 204–206. doi: 10.1016/j.ijcard.2016.03.202.Zhou Z, Chen X, Liu G, Pu J, Wu J. Presence of Multiple Autoimmune Antibodies Involved in Concurrent Myositis and Myocarditis and Myasthenia Gravis Without Thymoma: A Case Report. Front Neurol. 2019; 10: 770. doi: 10.3389/fneur.2019.00770.Zhou Z, Chen X, Liu G, Pu J, Wu J. Presence of Multiple Autoimmune Antibodies Involved in Concurrent Myositis and Myocarditis and Myasthenia Gravis Without Thymoma: A Case Report. Front Neurol. 2019; 10: 770. doi: 10.3389/fneur.2019.00770.Suarez-Barrientos A, Wong J, Bell A, Lyster H, Karagiannis G, Banner NR. Usefulness of Rabbit Anti-thymocyte Globulin in Patients With Giant Cell Myocarditis. Am J Cardiol. 2015; 116 (3): 447–451. doi: 10.1016/j.amjcard.2015.04.040.Suarez-Barrientos A, Wong J, Bell A, Lyster H, Karagiannis G, Banner NR. Usefulness of Rabbit Anti-thymocyte Globulin in Patients With Giant Cell Myocarditis. Am J Cardiol. 2015; 116 (3): 447–451. doi: 10.1016/j.amjcard.2015.04.040.Patel AD, Lowes B, Chamsi-Pasha MA, Radio SJ, Hyden M, Zolty R. Sirolimus for Recurrent Giant Cell Myocarditis After Heart Transplantation: A Unique Therapeutic Strategy. Am J Ther. 2019; 26 (5): 600–603. doi: 10.1097/MJT.0000000000000796.Patel AD, Lowes B, Chamsi-Pasha MA, Radio SJ, Hyden M, Zolty R. Sirolimus for Recurrent Giant Cell Myocarditis After Heart Transplantation: A Unique Therapeutic Strategy. Am J Ther. 2019; 26 (5): 600–603. doi: 10.1097/MJT.0000000000000796.Shevchenko AO, Nikitina EA, Koloskova NN, Shevchenko OP, Gautier SV. Controlled arterial hypertension and adverse event free survival rate in heart recipients. Cardiovascular therapy and prevention. 2018; 17 (4): 4–11. doi: 10.15829/1728-8800-2018-4-4-11.Шевченко АО, Никитина ЕА, Колоскова НН, Шевченко ОП, Готье СВ. Контролируемая артериальная гипертензия и выживаемость без нежелательных событий у реципиентов сердца. Кардиоваскулярная терапия и профилактика. 2018; 17 (4): 4–11. doi: 10.15829/1728-8800-2018-4-4-11.Montero S, Aissaoui N, Tadié JM, Bizouarn P, Scherrer V, Persichini R et al. Fulminant giant-cell myocarditis on mechanical circulatory support: Management and outcomes of a French multicentre cohort. Int J Cardiol. 2018; 253: 105–112. doi: 10.1016/j.ijcard.2017.10.053.Montero S, Aissaoui N, Tadié JM, Bizouarn P, Scherrer V, Persichini R et al. Fulminant giant-cell myocarditis on mechanical circulatory support: Management and outcomes of a French multicentre cohort. Int J Cardiol. 2018; 253: 105–112. doi: 10.1016/j.ijcard.2017.10.053.Fallon JM, Parker AM, Dunn SP, Kennedy JLW. A giant mystery in giant cell myocarditis: navigating diagnosis, immunosuppression, and mechanical circulatory support. ESC Heart Fail. 2020; 7 (1): 315–319. doi: 10.1002/ehf2.12564.Fallon JM, Parker AM, Dunn SP, Kennedy JLW. A giant mystery in giant cell myocarditis: navigating diagnosis, immunosuppression, and mechanical circulatory support. ESC Heart Fail. 2020; 7 (1): 315–319. doi: 10.1002/ehf2.12564.Elamm CA, Al-Kindi SG, Bianco CM, Dhakal BP, Oliveira GH. Heart Transplantation in Giant Cell Myocarditis: Analysis of the United Network for Organ Sharing Registry. J Card Fail. 2017; 23 (7): 566–569. doi: 10.1016/j.cardfail.2017.04.015.Elamm CA, Al-Kindi SG, Bianco CM, Dhakal BP, Oliveira GH. Heart Transplantation in Giant Cell Myocarditis: Analysis of the United Network for Organ Sharing Registry. J Card Fail. 2017; 23 (7): 566–569. doi: 10.1016/j.cardfail.2017.04.015.Elamm CA, Al-Kindi SG, Bianco CM, Dhakal BP, Oliveira GH. Heart Transplantation in Giant Cell Myocarditis: Analysis of the United Network for Organ Sharing Registry. J Card Fail. 2017; 23 (7): 566–569. doi: 10.1016/j.cardfail.2017.04.015.
The authors declare that there are no conflicts of interest present.